Fischer Medical Ventures Limited
All news and filings related to Fischer Medical Ventures Limited.
View all news & filings- Low impact
Fischer Medical Ventures Holds 33rd AGM via Video Conference on Sep 29, 2026
Fischer Medical Ventures Limited held its 33rd AGM on September 29, 2026, via video conference. Key management, including Chairman Mr. Ravindran Govindan and CFO Mr. Vivek Balasubramanian, addressed shareholder queries on international operations, growth, and financials. E-voting was conducted with NSDL facilitating the process.
Read the summary - Medium impact
Fischer Medical Ventures Subsidiaries Declare Dividends Totaling ₹17.5 Crore
Fischer Medical Ventures Limited's subsidiaries have declared significant dividends. Time Medical declared ₹6.5 crore, FlynnCare declared ₹10 crore for FY26. FMV Global Innovation approved an interim dividend of USD 1,100,000 for FY27.
Read the summary - Low impact
Fischer Medical Ventures Issues Corrigendum for FY26 Annual Report, Correcting Key Financial and Auditor Details
Fischer Medical Ventures Limited issued a corrigendum for its FY 2025-26 Annual Report, correcting errors in financial highlights, auditor's reports, equity share capital, and financial tables. The updated report addresses discrepancies on pages 70, 136, 182, 147, 193, 171, 173, 220, and 222. The original report was dispatched on September 7th, 2026.
Read the summary - Low impact
Fischer Medical Ventures: Trading Window Closed Oct 1 for Q2 FY27 Results
Fischer Medical Ventures Limited will close its trading window from October 01, 2026. The window will reopen 48 hours after the declaration of Un-Audited Financial Results for the quarter ended September 30, 2026. This affects Promoters, Directors, and Designated Persons.
Read the summary - Medium impact
Fischer Medical Ventures Approves Rights Issues in Subsidiaries
Fischer Medical Ventures' Board approved rights issues for subsidiaries Time Medical, Flynn Care, and FMV Global. The company will invest in these rights issues. Time Medical issued shares at ₹7,370.25, Flynn Care at ₹82,943.48, and FMV Global at ₹48,83,552.64.
Read the summary - Low impact
Fischer Medical Ventures Submits Revised Investor Presentation
Fischer Medical Ventures Limited has submitted a revised investor presentation to stock exchanges. The revised document pertains to an investor/analyst call held on September 7, 2026, and is in compliance with SEBI regulations.
Read the summary - High impact
Fischer Medical Ventures Expands Global Reach with New Ventures in Radiology and Diagnostics
Fischer Medical Ventures is expanding its global footprint with new ventures in radiology and diagnostics. The company is developing advanced MRI and CT systems, including India's first helium-free 1.5T MRI. International expansion includes a 4T4TB solution in Indonesia and an MRI installation in the Philippines. A new AI-powered rehabilitation center concept is planned for Malaysia, and an AI molecular research platform, Vecura, is being introduced to India. The promoter group infused ₹59.67 crore, increasing their stake.
Read the summary - Low impact
Fischer Medical Ventures Announces AGM on Sep 29, 2026
Fischer Medical Ventures Limited will hold its Annual General Meeting on September 29, 2026, at 11:00 AM IST. The notice of the AGM was published in "Financial Express" and "Vishalandra" on September 9, 2026.
Read the summary - Low impact
Fischer Medical Ventures Presents Investor Deck for Analyst Call
Fischer Medical Ventures Limited held an investor and analyst call on September 7, 2026. The company presented its strategy to build the largest Healthcare AI Solutions Platform, focusing on AI-enabled medical imaging, population screening, and hospital digitization. The presentation detailed its corporate structure and board of directors.
Read the summary - Low impact
Fischer Medical Ventures to hold AGM 2026 via Video Conference
Fischer Medical Ventures Limited will conduct its 2026 AGM via Video Conference. The Annual Report for FY2025-26 will be sent electronically. Newspaper advertisements were published on September 5, 2026.
Read the summary - Low impact
Fischer Medical Ventures to Hold One-on-One Investor Meet on Sep 7
Fischer Medical Ventures Limited will host a virtual one-on-one meeting with institutional investors on September 7, 2026. The discussion will focus on the company's business and publicly available information.
Read the summary - Medium impact
Fischer Medical Ventures Appoints David Yeow as Independent Director, Sets AGM Date
Fischer Medical Ventures appointed David Yeow as Additional Independent Director for a five-year term. The company will hold its 33rd AGM on September 29, 2026, via video conference. The Register of Members will close from September 23-29, 2026. The Audit Committee has also been reconstituted.
Read the summary - Medium impact
Fischer Medical Ventures Appoints David Yeow as Independent Director, Reconstitutes Audit Committee
Fischer Medical Ventures appointed Mr. David Yeow as Additional Independent Director from September 3, 2026. The Audit Committee was reconstituted. The 33rd AGM will be held on September 29, 2026. The register of members will close from September 23 to September 29, 2026.
Read the summary - Low impact
Fischer Medical Ventures Sets Record Date for AGM and Dividend
Fischer Medical Ventures Limited has set September 22, 2026, as the record date for dividend and AGM voting rights. The AGM is scheduled for September 29, 2026. The register of members will be closed from September 23 to September 29, 2026. The cut-off for AGM notice dispatch is September 4, 2026.
Read the summary - Medium impact
Fischer Medical Ventures subsidiary launches AI-Driven CT System in India
Fischer Medical Ventures' subsidiary, TMIV Imaging, launched the CLARION 64/128-Slice AI-Driven CT System in India at the India Health Expo 2026. The system features advanced AI, enhanced imaging capabilities, and intelligent workflows for improved diagnostic care and operational efficiency.
Read the summary - Medium impact
Fischer Medical Ventures Subsidiary Awarded Digital Healthcare Project in Philippines
Fischer Medical Ventures Limited's subsidiary, Time Medical Philippines, has been awarded a province-wide digital healthcare project in Catanduanes Province. The project integrates Health Kiosks with the FlynnCare Clinic Management System to enhance digital healthcare accessibility and support the Philippines' Universal Health Care program.
Read the summary - Low impact
Fischer Medical Ventures Allots 4.54 Lakh Equity Shares on Warrant Conversion
Fischer Medical Ventures Limited approved the allotment of 4,54,210 equity shares upon conversion of warrants by promoter FMV Holdings Pte Ltd. The shares were issued at ₹23.40 each, with the company receiving ₹79,71,385.50 as the remaining exercise price.
Read the summary - Medium impact
Fischer Medical Ventures Converts Warrants to 2.05 Cr Equity Shares, Raises ₹35.98 Cr
Fischer Medical Ventures Limited's board approved the conversion of 2,05,05,909 warrants into equity shares at ₹23.40 each. The company raised ₹35.98 crore through this conversion. Major conversions were by Mr. Shankar Varadharajan (60L warrants), FMV Holdings Pte Ltd (73.36L warrants), and Vritti Hitesh Kawa (71.70L warrants).
Read the summary - Low impact
Fischer Medical Ventures: Two Independent Directors Resign Effective August 14
Fischer Medical Ventures Limited announced the resignation of two Independent Directors, Mr. Roberto M Pagdanganan and Mr. Sanjay Jayantilal Jain. Their resignations are effective August 14, 2026, due to personal reasons and other professional commitments.
Read the summary - Medium impact
Fischer Medical Ventures Converts 66.3 Lakh Warrants into Equity, Raises ₹11.64 Crore
Fischer Medical Ventures Limited converted 66.31 lakh warrants into equity shares on August 12, 2026. The issue price was ₹23.40 per share, raising ₹11.64 crore. Allottees include Mr. Shankar Varadharajan and FMV Holdings Pte Ltd, both promoters.
Read the summary - Medium impact
Fischer Medical Ventures Allots 23 Lakh Equity Shares on Warrant Conversion
Fischer Medical Ventures Limited allotted 23,00,000 equity shares upon conversion of warrants. The issue price was ₹23.40 per share. The company received ₹4,03,65,000. Mr. Shankar Varadharajan, a promoter, was the allottee.
Read the summary - Low impact
Fischer Medical Ventures Announces Special Window for Physical Share Transfer Requests
Fischer Medical Ventures has opened a special window for re-lodging transfer requests for physical shares. This window is active from February 05, 2026, to February 04, 2027. Shareholders with rejected or incomplete transfer requests due to documentation issues can resubmit them.
Read the summary - Medium impact
Fischer Medical Ventures Subsidiary Partners with Parul University for MRI Suite Installation
Fischer Medical Ventures' subsidiary, Time Medical India, partnered with Parul Sevashram Hospital to install its AI-enabled intraoperative MRI system, the DRIS–iMRI Medharanya Suite. This marks the first such installation in India, aiming to enhance neurosurgical precision and provide advanced clinical exposure.
Read the summary - High impact
Fischer Medical Ventures Secures CDSCO Import Approval for Spincare Wound Care System
Fischer Medical Ventures' associate, Nanomedic Technologies, received CDSCO import approval for the Spincare Portable Wound Care System in India. This Class C medical device uses electrospun nanofiber technology for wound care. Fischer holds exclusive distribution rights for India and Southeast Asia, targeting a combined market valued in billions.
Read the summary - Low impact
Fischer Medical Ventures Clarifies Financial Results Submission Delay Due to Technical Issues
Fischer Medical Ventures clarified to NSE that it operates in a single business segment. The company faced technical issues with the NEAPS portal, causing a delay in submitting its financial results and dividend recommendation, which were ultimately filed on May 30, 2026.
Read the summary - Low impact
Fischer Medical Ventures Files SEBI Certificate for Quarter Ended June 30, 2026
Fischer Medical Ventures Limited has submitted a certificate for the quarter ended June 30, 2026, as per SEBI regulations. The certificate was issued by its Registrar and Share Transfer Agent, confirming the processing of dematerialised securities.
Read the summary - Low impact
Fischer Medical Ventures: Trading Window Closed for Q1 FY27 Results
Fischer Medical Ventures Limited has closed its trading window for insiders from July 01, 2026. The closure is effective until 48 hours post-declaration of the un-audited financial results for the quarter ended June 30, 2026.
Read the summary - Medium impact
Fischer Medical Ventures approves FY26 results, recommends dividend of ₹0.05/share
Fischer Medical Ventures reported its audited financial results for the quarter and year ended March 31, 2026. The company recommended a final dividend of ₹0.05 per equity share. S. Ramanand Aiyer & Co. has been appointed as the Internal Auditors for FY27.
Read the summary - Medium impact
Fischer Medical Ventures Approves FY26 Results, Recommends Dividend
Fischer Medical Ventures approved audited standalone and consolidated financial results for FY26. The company recommended a final dividend of ₹0.05 per equity share. S. Ramanand Aiyer & Co. were appointed as internal auditors for FY27.
Read the summary - Low impact
Fischer Medical Ventures: Monitoring Agency Report for Q4FY26 Shows No Deviation in Fund Utilization
Fischer Medical Ventures' Monitoring Agency Report for Q4FY26 confirms no deviation in fund utilization from its Rs. 358.46 crore preferential issue. Rs. 10.53 crore was utilized for loan repayment to subsidiary TMVIPL. Cumulative utilization is Rs. 280.93 crore, aligning with offer document goals.
Read the summary - Medium impact
Fischer Medical Ventures Subsidiary Partners with WFNS for Neuro-Innovation
Fischer Medical Ventures Limited's subsidiary, Time Medical India, has partnered with the WFNS Innovation & Technology Committee. This collaboration aims to advance global neurosurgical innovation through cutting-edge technologies and training. It marks a historic first for the WFNS committee in formally engaging an industry partner.
Read the summary - Low impact
Fischer Medical Ventures: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fischer Medical Ventures Limited received a certificate for the quarter ended March 31, 2026, under SEBI (Depositories and Participants) Regulations. The RTA confirmed dematerialisation processing and cancellation of old certificates.
Read the summary - Low impact
Fischer Medical Ventures: Promoter declares no new share encumbrances for FY26
Shankar Varadharaajan, promoter of Fischer Medical Ventures, declared no new share encumbrances for FY26 under SEBI Takeover Regulations. This applies to the promoter group including FMV Holdings Pte Ltd and Mr. Ravindran Govindan. All previously disclosed encumbrances remain unchanged.
Read the summary - Medium impact
Fischer Medical Ventures Allots 60 Lakh Equity Shares on Warrant Conversion, Raises ₹10.53 Crore
Fischer Medical Ventures Limited converted 60 lakh warrants into equity shares on March 31, 2026. Promoter Mr. Shankar Varadharajan exercised the option, raising ₹10.53 crore for the company. The issue price was ₹23.40 per share.
Read the summary - Low impact
Fischer Medical Ventures: Trading Window Closed for Audited Financial Results
Fischer Medical Ventures Limited will close its trading window from April 01, 2026. This closure is to comply with SEBI regulations regarding insider trading. The window will reopen 48 hours after the declaration of audited financial results for the year ending March 31, 2026. A separate notice will be issued for the board meeting to approve these results.
Read the summary - Low impact
Fischer Medical Ventures Appoints Balaji Gandla as Company Secretary & Compliance Officer
Fischer Medical Ventures Limited appointed Mr. Balaji Gandla as Company Secretary and Compliance Officer, effective March 24, 2026. Gandla is a qualified CS with over a decade of experience in corporate governance and compliance.
Read the summary - Low impact
Fischer Medical Ventures Closes Trading Window March 21-24 for Board Meeting
Fischer Medical Ventures Limited will close its trading window from March 21, 2026, until 48 hours after the board meeting on March 24, 2026. The board meeting will consider the appointment of a new Company Secretary and Compliance Officer.
Read the summary - Low impact
Fischer Medical Ventures Announces Special Window for Physical Share Transfer Re-lodgement
Fischer Medical Ventures Limited announced a special window for re-lodging transfer requests for physical shares. This window is open from February 5, 2026, to February 4, 2027. The company published this information in "Financial Express" and "Vishalandra" on March 12, 2026.
Read the summary - Medium impact
Fischer Medical Ventures Subsidiary Invests 75% in PT Fischer Pariko Medical Ventures
Fischer Medical Ventures' subsidiary, FMV Global Innovations Pte Limited, has acquired a 75% stake in PT Fischer Pariko Medical Ventures. The target entity, incorporated in Indonesia on October 14, 2024, operates in the medical equipment wholesale sector and has no prior turnover.
Read the summary - Low impact
Fischer Medical Ventures: Monitoring Agency Report for Q3FY26 Shows No Deviation in Fund Utilization
Fischer Medical Ventures Limited's Monitoring Agency Report for the quarter ended December 31, 2025, confirms no deviation in the utilization of ₹358.46 crore raised via preferential issue. All funds received by Q1FY26 are fully utilized. The company's growth objectives and general corporate purposes are on track with no delays.
Read the summary - Medium impact
Fischer Medical Ventures' subsidiary launches advanced 1.5T MRI platforms MICA and QUIN
Fischer Medical Ventures' subsidiary, Time Medical India, launched two new 1.5T MRI platforms, MICA and QUIN, at IRIA 2026. MICA is a 32-channel system with zero boil-off magnet technology. QUIN is India's first helium-free 1.5T MRI system with a 70cm bore, available in 32/64 channels. Both have received CDSCO certification.
Read the summary - Low impact
Fischer Medical Ventures Clarifies Single Business Segment in Financial Results
Fischer Medical Ventures Limited clarified to the NSE that it operates in a single business segment: Healthcare Equipment and Supplies. This was in response to an observation regarding the non-submission of segment details in financial results submitted on January 30, 2026.
Read the summary - Low impact
Fischer Medical Ventures: Company Secretary Mr. AravindKumar V Resigns
Mr. AravindKumar V has resigned as Company Secretary and Compliance Officer of Fischer Medical Ventures Limited and its subsidiary. His resignation is effective February 10, 2026, due to personal reasons and career growth opportunities.
Read the summary - Low impact
Fischer Medical Ventures: Company Secretary Resigns Effective Feb 10, 2026
Mr. AravindKumar V has resigned as Company Secretary of Fischer Medical Ventures Limited and its subsidiary. His resignation is effective February 10, 2026, due to personal reasons and seeking career growth. The board noted and approved the resignation during their meeting on January 30, 2026.
Read the summary - Low impact
Fischer Medical Ventures Ltd Subsidiary Secures ₹40 Crore Loan from HDFC Bank
Fischer Medical Ventures Ltd's subsidiary, Time Medical International Ventures (India) Private Limited, secured a ₹40 Crore secured loan from HDFC Bank Ltd. The loan agreement was executed on January 30, 2026, with shares pledged and FD collateral provided. The interest rate is 3 months Repo + 2.75% p.a.
Read the summary - Medium impact
Fischer Medical Ventures Approves Restructuring of Malaysian Subsidiary Shareholding
Fischer Medical Ventures Limited approved restructuring of its Malaysian subsidiary, Fischer Hospitality Sdn. Bhd. A Malaysian trustee will hold 51% of FHSB on behalf of the company, which will hold the remaining 49%. The subsidiary is in investment holding and has not yet commenced business.
Read the summary - Medium impact
Fischer Medical Ventures Board Approves Financial Results, Restructures Malaysian Subsidiary
Fischer Medical Ventures Limited approved unaudited financial results for Q3FY26. Mr. Aravindkumar V resigned as Company Secretary & Compliance Officer, effective Feb 10, 2026. The company will restructure its Malaysian subsidiary, Fischer Hospitality Sdn. Bhd., with a trustee holding 51% on behalf of Fischer. A fine was noted for delayed RPT filings.
Read the summary - Medium impact
Fischer Medical Ventures Board Approves Q3 Results, Restructures Malaysian Subsidiary, Accepts CS Resignation
Fischer Medical Ventures Limited's Board approved unaudited Q3 results. The company will restructure its Malaysian subsidiary, Fischer Hospitality Sdn. Bhd., with a trustee holding 51% on behalf of the company. Mr. Aravindkumar V resigned as Company Secretary, effective February 10, 2026. The board also addressed a past non-compliance regarding related party transactions.
Read the summary - Low impact
Fischer Medical Ventures Approves Share Transfer in Foreign Subsidiary for Reorganisation
Fischer Medical Ventures Limited approved the transfer of shares in its Singapore subsidiary, PellucidCare Health Innovations Pte Ltd, to its wholly owned subsidiary, FlynnCare Health Innovations Private Limited. This is part of an internal group reorganisation for operational efficiency. No change in ultimate ownership or control is expected.
Read the summary - Low impact
Fischer Medical Ventures: Newspaper Ad on Securities Transfer Request
Fischer Medical Ventures Limited published a newspaper advertisement on January 7, 2026, regarding a request for securities transfer by Mr. Anil Kedia. The notice invites claims from interested parties within the stipulated period.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio